FranΓ§aisπ See the interactive version (live chart) β
| Investment | Value today | Gain |
|---|---|---|
| 1 years ago (2025) | $1,430 | +43% |
| 3 years ago (2023) | $2,386 | +139% |
| 5 years ago (2021) | $1,157 | +16% |
| 10 years ago (2016) | $7,864 | +686% |
| since 2013 | $4,362 | +336% |
| Year | Year's return | $1,000 invested at year start β worth today |
|---|---|---|
| 2026 (YTD) | +34% | $1,345 (+34%) |
| 2025 | +6% | $1,430 (+43%) |
| 2024 | +44% | $2,058 (+106%) |
| 2023 | +16% | $2,386 (+139%) |
| 2022 | -42% | $1,374 (+37%) |
| 2021 | -16% | $1,157 (+16%) |
| 2020 | +75% | $2,028 (+103%) |
| 2019 | +122% | $4,501 (+350%) |
| 2018 | +93% | $8,671 (+767%) |
| 2017 | -16% | $7,315 (+632%) |
| 2016 | +7% | $7,864 (+686%) |
π See the analyst analysis of Veracyte, Inc. β
$1000 invested in Veracyte, Inc. 5 years ago would be worth $1,157 today, and $7,864 over 10 years (price return, excluding dividends).
Calendar-year returns β 2024: +44%. 2025: +6%. 2026: +34%. Full breakdown in the table above.
Over 10 years, Veracyte, Inc.'s average annual return (CAGR) is about 23% per year, and 3%/yr over 5 years.
Best year: 2019 (+122%). Worst year: 2022 (-42%).
It's proportional β just multiply. Over 5 years, $1,000 invested in Veracyte, Inc. is worth $1,157, so $100 would be worth a tenth, $5,000 five times more, and $10,000 ten times more. Use the calculator at the top of the page for your exact amount and chosen year.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Past performance, no predictive value and not investment advice. Prices in $, excluding dividends. Data: Yahoo Finance.